Infliximab (Remicade)

Remicade (infliximab) is a biologic medicine that helps the pain and swelling of arthritis. It works by blocking Tumor Necrosis Factor (TNF), a type of signalling protein (called a cytokine), that is involved in systemic inflammation. Remicade belongs to a class of similar medications called Anti-Tumor Necrosis Factor agents.

Remicade is used in the treatment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Ulcerative Colitis, Psoriasis, and other types of arthritis.

Remicade may be prescribed in combination with other rheumatology medications like methotrexate.

Taking Remicade

Remicade is administered by intravenous infusion at specialized clinics.

Some patients start to feel better quickly with Remicade, but in others, it can take a little longer.

It’s important for patients starting this medication to give it some time and keep receiving infusions as prescribed by their doctor.

The manufacturer of Remicade offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks




Watch Canadian rheumatologist Dr. Andy Thompson introduce Remicade in this short video:


Remicade Quick Reference Guide

Drug Identification Number (DIN)

  • 02244016 (IV)